View More Recent Stories

May 10, 2016 04:05PM Intrexon Announces First Quarter 2016 Financial Results
May 5, 2016 08:00AM Fibrocell Reports First Quarter 2016 Financial Results and Operational Highlights
Apr 28, 2016 08:00AM Fibrocell to Host Conference Call and Webcast on Thursday, May 5, 2016 to Discuss First Quarter 2016 Financial Results and Recent Operational Highlights
Apr 21, 2016 08:07AM Fibrocell Science (FCSC) Announces Final Patient Visit for Azficel-T Phase 2 Primary Endpoint (XON)
Apr 21, 2016 08:00AM Fibrocell Announces Last Patient Visit for Primary Endpoint Analysis in Phase II Clinical Trial of azficel-T for the Treatment of Vocal Cord Scarring
Apr 18, 2016 08:07AM Fibrocell Science (FCSC) Receives FDA Allowance to Commence FCX-007 Phase 1/2 in RDEB (XON)
Apr 18, 2016 08:00AM Fibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Sep 22, 2014 10:00AM Fibrocell Science, Inc. (NASDAQ: FCSC) to Ring The NASDAQ Stock Market Opening Bell
View More Recent Stories